Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled (Q78505423)
Jump to navigation
Jump to search
scientific article published on 01 November 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled |
scientific article published on 01 November 2002 |
Statements
Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial (English)
George Nuki
Barry Bresnihan
Moraye B Bear
Dorothy McCabe
European Group Of Clinical Investigators
1 November 2002